Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of fluticasone furoate inhalation powder in children with persistent uncontrolled asthma
2011-003338-15Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of fluticasone in asthma and persistent asthma (4 arms), sponsored by GSK. Primary endpoint: Change from baseline in pre-dose evening peak expiratory flow at endpoint. Started Feb 2012; status: completed.
02
Drugs
fluticasone
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2011-003338-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003338-15.